News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Repros Therapeutics Inc. Announces Dismissal of Class Action Lawsuits
March 4, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc.® (NasdaqCM:RPRX, RPRXW and RPRXZ) today announced that the pending class action securities lawsuits that were filed against it during 2009 have been dismissed.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Patents
Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant
March 4, 2026
·
2 min read
·
Tristan Manalac
CDC
RFK Jr. Appoints 2 New Advisors to CDC Vaccine Panel Ahead of March Meeting
March 2, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule
February 27, 2026
·
2 min read
·
Nick Paul Taylor
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
February 27, 2026
·
6 min read
·
Heather McKenzie
